• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Inspections, Compliance, Enforcement, and Criminal Investigations

  • Print
  • Share
  • E-mail
-
 

2000 Warning Letters

-

Recently Posted | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 |

Tobacco Retailer Warning Letters

 

-

Warning Letters for 2000

Recently Posted | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996

 

* Not issued: A close-out letter may issue when, based on FDA’s evaluation, the firm has taken corrective action to address the violations contained in the Warning Letter. This procedure applies to Warning Letters issued on or after September 1, 2009.

* N/A: Not applicable, the Warning Letter was issued prior to September 1, 2009.

Read more about warning and close-out letters

 
Letter Issue Date Company Name Issuing Office Subject Close Out Date
December 14, 2000 Airgas Norpac [ARCHIVED] Seattle District Office Medical Gas/Adulterated N/A *
December 14, 2000 San Dimas Community Hospital [ARCHIVED] Los Angeles District Office Mammography Standards N/A *
December 14, 2000 Intercoastal Medical Group [ARCHIVED] Florida District Office Mammography Standards N/A *
December 13, 2000 Everett Clinic [ARCHIVED] Seattle District Office Mammography Standards N/A *
December 12, 2000 University OB-GYN Specialties Inc. [ARCHIVED] Cincinnati District Office Mammography Standards N/A *
December 12, 2000 Scholzen Products Company Inc. [ARCHIVED] Denver District Office GMP for Finished Pharmaceuticals/Gas & Liquid Medical Oxygen/Adulterated N/A *
December 11, 2000 Chemrich Holdings Inc. [ARCHIVED] Los Angeles District Office Manufacturing Facility/Current Good Manufacturing Practices for Finished Pharmaceuticals/Adulterated N/A *
December 11, 2000 Leiner Health Products Inc. [ARCHIVED] Atlanta District Office Good Manufacturing Practice for Finished Pharmaceuticals/Adulterated N/A *
December 11, 2000 Holy Cross Hospital [ARCHIVED] Dallas District Office Mammography Standards N/A *
December 11, 2000 Radiology Clinics of Laredo [ARCHIVED] Dallas District Office Mammography Standards N/A *
December 08, 2000 JFC International Inc. [ARCHIVED] San Francisco District Office Seafood Processing Regulations/HACCP N/A *
December 08, 2000 Tonnage and Applied Gas Solutions [ARCHIVED] New Orleans District Office Liquid Carbon Dioxide/Good Manufacturing Practices for Finished Pharmaceuticals/Adulterated N/A *
December 08, 2000 Ellis Hospital [ARCHIVED] New York District Office Mammography Standards N/A *
December 07, 2000 Coolidge Dairy Farm [ARCHIVED] Kansas City District Office Dairy Operation/Adulterated N/A *
December 06, 2000 Port of Stockton Ore Dock 2-13 [ARCHIVED] San Francisco District Office Insanitary Conditions/Backflow Prevention Devices N/A *
December 06, 2000 Farmers Coop Association [ARCHIVED] Kansas City District Office Good Manufacturing Practice Regulation for Medicated Feeds/Medicated Feed Mill/Adulterated N/A *
December 06, 2000 Societa Italiana Medicinali Scandicci [ARCHIVED] Center for Drug Evaluation and Research Good Manufacturing Practices for Active Pharmaceutical Ingredient N/A *
December 06, 2000 Women's Diagnostic Center at Enumclaw Community Hospital [ARCHIVED] Seattle District Office Mammography Standards N/A *
December 06, 2000 Duramed Pharmaceuticals Inc. [ARCHIVED] New Jersey District Office Good Manufacturing Processing Packing Holding/Finished Pharmaceuticals/Adulterated N/A *
December 06, 2000 SHARP Chula Vista Imaging Center [ARCHIVED] Los Angeles District Office Mammography Standards N/A *



-
 

Contact FDA

ICECI Warning Letters

Division of Freedom of Information (HFI-35)

Food and Drug Administration

5600 Fishers Lane

Rockville, MD 20857
-
-
-
-